Synthetic lethality company Ideaya raises $94M

By Chris Lieu | Mar 16, 2018 | 4:58 PM GMT

Ideaya Biosciences Inc. (South San Francisco, Calif.) raised $94 million in a series B round on March 15

Read the full 186 word article

How to gain access

Continue reading with a
two-week free trial.